Jeff Zimmer
Analyst · Christopher Nolan with Ladenburg Thalmann & Co. Please proceed with your question
So, let me talk about selling positions, I also said to Trevor; we might sell, as I said, some three-and-halves -- 15 years, our lower-yielding assets or maybe some stuff to buy some longer assets, if we build, the market stabilize a little bit, but we'd rather watch for a while and see what happens. So, yes, the capacity and the ability to do that particularly with our lower leverage numbers are definitely there. And we got to look forward to the opportunity, because if we create surprise on the earnings side down the road. Now, in the stewardship of capital or buybacks, let me address that; stewardship, again, the stewardships of ARMOUR's equity is the primary responsibility of both our management team and of course the Board of Director's customer. This group accesses regularly the benefits or detriments of issuing equity or repurchasing equity in the secondary marketplace. Okay? So, typically, as I said in earnings calls before, I remember in early late '15 and '16 when we were trading well under book value, three things generally, the place to issue equity, so I want to talk about both sides of it. So, we are very clear, and if you had it writing up, you know, this is stuff I could -- please feel free to call me back, and I can give you a little more detail or try to repeat what we talked about. The issue, I agree there must be beneficial use of proceeds, meaning the investment of ARMOUR was promised -- the opportunity to improve the company's portfolio, let's say. Accretive offerings are always preferred, but current shareholders should not be diluted to the extent that the other benefits of issuance clearly outweigh the dilution, let's say. The secondary market is also expected to absorb any new issued shares without disturbed. Okay? So, you get a short-term disturbance and you've been involved in our secondary before you format, but you wanted to stabilize after a week or so. So, that's the issue. So, let's get to your point. Some of the considerations that the Board studies for repurchases of equity are typically the -- there're four or five things, let's see, is the current liquidity of the company such that our repurchase would not negatively affect continuing operations. So that's number one. Is that a good moment in time in the bond and swap markets to be a seller rather than a buyer, because remember, if you reduce your equity, your leverage goes up, or you have to sell bonds and you have to unwind swaps. Well, we are not worried about that. We are probably the better buyers of bonds. We back up a little more. So, we don't think it's a good time to do that right now. Our shareholders better off with the accruals that makes the company permanently smaller and less operationally of vision; something that we talk about. Best alternatives are available that can potentially be better use of bonds and buying former stocks. And the buybacks have a permanent better effect on our stock prices. Let me just get to one or two things. If we were to repurchase, and this is the work we did for the Board meeting the other day, if we repurchased $50 million of stock, today we'd get about $0.14 accretion of book value. It would increase our annualized expenses by $3.9 or $4.0 a share. Our average daily book value change in 2017 was $0.9 a day. So, for us, with the liquidity as it is right now, we don't really see it at a good, and our Board completely agrees of reinvesting at ARMOUR stock. But the record shows that we're willing and able -- really able to repurchase significant amounts of stock in the right circumstances. In 2013 to '15, we repurchased $250 million for the stock, and it is something that we look at regularly, but we're not planning to do it this week, and we would like to get through this volatile period of time, and we will reassess. So, I know that's a long answer, but I hope that address the question appropriately for you.